Speakers: Lena Friberg & Elisabet Nielsen, Department of Pharmaceutical Biosciences, Uppsala University, Sweden
Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria
In this webinar, Lena Friberg and Elisabet Nielsen discussed:
- Population PK modelling to characterize drug exposure and variability
- PKPD-modelling to characterize preclinical time-kill data
- PKPD-modelling for translation to patients
- Model-based dose-individualization
This live webinar including interactive Q&A session was broadcast on 20 August 2019.
If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us per email: email@example.com.